BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rabinovici GD, Wang PN, Levin J, Cook L, Pravdin M, Davis J, DeArmond SJ, Barbaro NM, Martindale J, Miller BL, Geschwind MD. First symptom in sporadic Creutzfeldt-Jakob disease. Neurology 2006;66:286-7. [PMID: 16434680 DOI: 10.1212/01.wnl.0000196440.00297.67] [Cited by in Crossref: 82] [Cited by in F6Publishing: 55] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Kim JH, Choi BS, Jung C, Chang Y, Kim S. Diffusion-weighted imaging and magnetic resonance spectroscopy of sporadic Creutzfeldt–Jakob disease: correlation with clinical course. Neuroradiology 2011;53:939-45. [DOI: 10.1007/s00234-010-0820-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
2 Taha MA, Diesing TS. Uncertainty of leukoencephalopathies: a case report. J Med Case Rep 2021;15:561. [PMID: 34784967 DOI: 10.1186/s13256-021-03089-6] [Reference Citation Analysis]
3 Tee BL, Longoria Ibarrola EM, Geschwind MD. Prion Diseases. Neurol Clin 2018;36:865-97. [PMID: 30366560 DOI: 10.1016/j.ncl.2018.07.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 7.7] [Reference Citation Analysis]
4 Ortega-cubero S, Pagola I, Luquin M, Viteri C, Pastor P, Gállego Pérez-larraya J, de Castro P, Domínguez I, Irimia P, Martínez-vila E, Arbizu J, Riverol M. Descripción de una serie de pacientes con diagnóstico de enfermedad priónica. Neurología 2015;30:144-52. [DOI: 10.1016/j.nrl.2013.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
5 Annus Á, Csáti A, Vécsei L. Prion diseases: New considerations. Clin Neurol Neurosurg 2016;150:125-32. [PMID: 27656779 DOI: 10.1016/j.clineuro.2016.09.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
6 Dirzius E, Balnyte R, Steibliene V, Gleizniene R, Gudinaviciene I, Radziunas A, Petrikonis K. Sporadic Creutzfeldt-Jakob disease with unusual initial presentation as posterior reversible encephalopathy syndrome: a case report. BMC Neurol 2016;16:234. [PMID: 27876002 DOI: 10.1186/s12883-016-0751-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Tsou A, Chen P, Tsai K, Hu W, Lu K. THαβ Immunological Pathway as Protective Immune Response against Prion Diseases: An Insight for Prion Infection Therapy. Viruses 2022;14:408. [DOI: 10.3390/v14020408] [Reference Citation Analysis]
8 Elahi FM, Miller BL. A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol 2017;13:457-76. [PMID: 28708131 DOI: 10.1038/nrneurol.2017.96] [Cited by in Crossref: 103] [Cited by in F6Publishing: 89] [Article Influence: 20.6] [Reference Citation Analysis]
9 Aslam S, Fritz MA, Cordes L, Sabbagh MN. What Promises the CJD Diagnosis in a Case of Rapidly Progressive Dementia? J Alzheimers Dis Parkinsonism 2018;8:452. [PMID: 30733890 DOI: 10.4172/2161-0460.1000452] [Reference Citation Analysis]
10 Bae MJ, Kang IH, Hur YR, Hwang KH. Sporadic Creutzfeldt-Jakob Syndrome Misdiagnosed as Recurrent Stroke: A Case Report. Ann Geriatr Med Res 2021;25:133-6. [PMID: 34120438 DOI: 10.4235/agmr.21.0030] [Reference Citation Analysis]
11 Sacco S, Paoletti M, Staffaroni AM, Kang H, Rojas J, Marx G, Goh SY, Luisa Mandelli M, Allen IE, Kramer JH, Bastianello S, Henry RG, Rosen HJ, Caverzasi E, Geschwind MD. Multimodal MRI staging for tracking progression and clinical-imaging correlation in sporadic Creutzfeldt-Jakob disease. Neuroimage Clin 2021;30:102523. [PMID: 33636540 DOI: 10.1016/j.nicl.2020.102523] [Reference Citation Analysis]
12 Rubin M, Graff-Radford J, Boeve B, Josephs KA, Aksamit AJ. The alien limb phenomenon and Creutzfeldt-Jakob disease. Parkinsonism Relat Disord 2012;18:842-6. [PMID: 22575235 DOI: 10.1016/j.parkreldis.2012.04.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
13 Coulthart MB, Jansen GH, Olsen E, Godal DL, Connolly T, Choi BC, Wang Z, Cashman NR. Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study. BMC Neurol 2011;11:133. [PMID: 22032272 DOI: 10.1186/1471-2377-11-133] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
14 Na S, Lee SA, Lee JD, Lee ES, Lee TK. Creutzfeldt-Jakob disease presenting with bilateral hearing loss: A case report. World J Clin Cases 2022; 10(18): 6333-6337 [DOI: 10.12998/wjcc.v10.i18.6333] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Rockwood K, Bouchard RW, Camicioli R, Léger G. Toward a revision of criteria for the dementias. Alzheimer's & Dementia 2007;3:428-40. [DOI: 10.1016/j.jalz.2007.07.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
16 Navid J, Day GS, Strain J, Perrin RJ, Bucelli RC, Dincer A, Wisch JK, Soleimani-Meigooni D, Morris JC, Benzinger TLS, Ances BM. Structural signature of sporadic Creutzfeldt-Jakob disease. Eur J Neurol 2019;26:1037-43. [PMID: 30735286 DOI: 10.1111/ene.13930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Roy M, Nath AK, Pal I, Dey SG. Second Sphere Interactions in Amyloidogenic Diseases. Chem Rev 2022. [PMID: 35471949 DOI: 10.1021/acs.chemrev.1c00941] [Reference Citation Analysis]
18 Senesi M, Lewis V, Kim JH, Adlard PA, Finkelstein DI, Collins SJ. In vivo prion models and the disconnection between transmissibility and neurotoxicity. Ageing Res Rev 2017;36:156-64. [PMID: 28450269 DOI: 10.1016/j.arr.2017.03.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Klotz DM, Penfold RS. Low mood, visual hallucinations, and falls - heralding the onset of rapidly progressive probable sporadic Creutzfeldt-Jakob disease in a 73-year old: a case report. J Med Case Rep 2018;12:128. [PMID: 29734943 DOI: 10.1186/s13256-018-1649-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Power B, Trivedi D, Samuel M. What psychiatrists should know about sporadic Creutzfeldt-Jakob disease. Australas Psychiatry 2012;20:61-6. [DOI: 10.1177/1039856211430145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
21 Tayyebi G, Malakouti SK, Shariati B, Kamalzadeh L. COVID-19-associated encephalitis or Creutzfeldt-Jakob disease: a case report. Neurodegener Dis Manag 2021. [PMID: 34854312 DOI: 10.2217/nmt-2021-0025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Gao T, Lyu JH, Zhang JT, Lou X, Zhao W, Xing XW, Yang M, Yao Y, Tan QC, Tian CL, Huang XS, Ma L, Yu SY. Diffusion-weighted MRI findings and clinical correlations in sporadic Creutzfeldt-Jakob disease. J Neurol 2015;262:1440-6. [PMID: 25860342 DOI: 10.1007/s00415-015-7723-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
23 Vallabh SM, Minikel EV, Schreiber SL, Lander ES. Towards a treatment for genetic prion disease: trials and biomarkers. Lancet Neurol 2020;19:361-8. [PMID: 32199098 DOI: 10.1016/S1474-4422(19)30403-X] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
24 Čiauškaitė J, Puleikytė I, Jesmanas S, Jurkevičienė G, Vaitkus A, Rastenytė D. Creutzfeldt-Jakob disease with neuroleptic malignant syndrome. Clin Case Rep 2021;9:e04699. [PMID: 34466255 DOI: 10.1002/ccr3.4699] [Reference Citation Analysis]
25 Carneiro AAM, Esmeraldo MA, Silva DEDLE, Ribeiro EML. Creutzfeldt-Jakob disease: literature review based on three case reports. Dement neuropsychol . [DOI: 10.1590/1980-5764-dn-2021-0107] [Reference Citation Analysis]
26 Feng S, Zhao X, Zhou X, Ye X, Yu X, Jiang W, Deng Y, Zhou S, Ma L, Shan P, Zhou G. Epidemiological and Clinical Characteristics of Sporadic Creutzfeldt-Jakob Disease: A Retrospective Study in Eastern China. Front Neurol 2021;12:700485. [PMID: 34690910 DOI: 10.3389/fneur.2021.700485] [Reference Citation Analysis]
27 Orrù CD, Soldau K, Cordano C, Llibre-Guerra J, Green AJ, Sanchez H, Groveman BR, Edland SD, Safar JG, Lin JH, Caughey B, Geschwind MD, Sigurdson CJ. Prion Seeds Distribute throughout the Eyes of Sporadic Creutzfeldt-Jakob Disease Patients. mBio 2018;9:e02095-18. [PMID: 30459197 DOI: 10.1128/mBio.02095-18] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
28 Rosenbloom MH, Atri A. The evaluation of rapidly progressive dementia. Neurologist 2011;17:67-74. [PMID: 21364356 DOI: 10.1097/NRL.0b013e31820ba5e3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
29 Chang C, Eggers SD, Johnson JK, Haman A, Miller BL, Geschwind MD. Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt–Jakob disease. Clinical Neurology and Neurosurgery 2007;109:54-7. [DOI: 10.1016/j.clineuro.2006.01.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
30 Takada LT, Kim MO, Cleveland RW, Wong K, Forner SA, Gala II, Fong JC, Geschwind MD. Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature. Am J Med Genet B Neuropsychiatr Genet 2017;174:36-69. [PMID: 27943639 DOI: 10.1002/ajmg.b.32505] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 11.4] [Reference Citation Analysis]
31 Pithon C, Leal GC, Quarantini LC, Rocha M. Creutzfeldt Jakob disease masquerading as severe depression: a case report. Arch Clin Psychiatry (São Paulo) 2018;45:106-106. [DOI: 10.1590/0101-60830000000168] [Reference Citation Analysis]
32 Sundaram SE, Staffaroni AM, Walker NC, Casaletto KB, Casey M, Golubjatnikov A, Metcalf S, O'Leary K, Wong K, Benisano K, Forner S, Gonzalez Catalan M, Allen IE, Rosen HJ, Kramer JH, Geschwind MD. Baseline neuropsychological profiles in prion disease predict survival time. Ann Clin Transl Neurol 2020;7:1535-45. [PMID: 33314770 DOI: 10.1002/acn3.51115] [Reference Citation Analysis]
33 El Tawil S, Chohan G, Mackenzie J, Rowe A, Weller B, Will RG, Knight R. Isolated language impairment as the primary presentation of sporadic Creutzfeldt Jakob Disease. Acta Neurol Scand 2017;135:316-23. [PMID: 27072062 DOI: 10.1111/ane.12600] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
34 Shiner E, Taylor L, Mohan A, Watson S, Sachdev PS. Severe depression masquerading as Creutzfeldt-Jakob disease. BMJ Case Rep 2014;2014:bcr2013203352. [PMID: 24748140 DOI: 10.1136/bcr-2013-203352] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Yegya-Raman N, Aziz R, Schneider D, Tobia A, Leitch M, Nwobi O. A Case of Sporadic Creutzfeldt-Jakob Disease Presenting as Conversion Disorder. Case Rep Psychiatry 2017;2017:2735329. [PMID: 28553554 DOI: 10.1155/2017/2735329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
36 Bagyinszky E, Kang MJ, Pyun J, Giau VV, An SSA, Kim S. Early-onset Alzheimer's disease patient with prion (PRNP) p.Val180Ile mutation. Neuropsychiatr Dis Treat 2019;15:2003-13. [PMID: 31410005 DOI: 10.2147/NDT.S215277] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
37 Tahir W, Abdulrahman B, Abdelaziz DH, Thapa S, Walia R, Schätzl HM. An astrocyte cell line that differentially propagates murine prions. J Biol Chem 2020;295:11572-83. [PMID: 32561641 DOI: 10.1074/jbc.RA120.012596] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
38 Geschwind MD, Shu H, Haman A, Sejvar JJ, Miller BL. Rapidly progressive dementia. Ann Neurol 2008;64:97-108. [PMID: 18668637 DOI: 10.1002/ana.21430] [Cited by in Crossref: 179] [Cited by in F6Publishing: 136] [Article Influence: 12.8] [Reference Citation Analysis]
39 Cohen OS, Prohovnik I, Korczyn AD, Ephraty L, Nitsan Z, Tsabari R, Appel S, Rosenmann H, Kahana E, Chapman J. The Creutzfeldt-Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression. Acta Neurol Scand 2011;124:368-74. [PMID: 21303352 DOI: 10.1111/j.1600-0404.2011.01489.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
40 Liu W, Lu Y, Zhong G, Jiang B, Pan Z. Clinical and MRI evaluation of anxiety as the first symptom of sporadic Creutzfeldt-Jakob disease: A case report. Exp Ther Med 2016;11:1513-5. [PMID: 27073474 DOI: 10.3892/etm.2016.3041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
41 Chitravas N, Jung RS, Kofskey DM, Blevins JE, Gambetti P, Leigh RJ, Cohen ML. Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol 2011;70:437-44. [PMID: 21674591 DOI: 10.1002/ana.22454] [Cited by in Crossref: 106] [Cited by in F6Publishing: 92] [Article Influence: 9.6] [Reference Citation Analysis]
42 Younes K, Rojas JC, Wolf A, Sheng-Yang GM, Paoletti M, Toller G, Caverzasi E, Luisa Mandelli M, Illán-Gala I, Kramer JH, Cobigo Y, Miller BL, Rosen HJ, Geschwind MD. Selective vulnerability to atrophy in sporadic Creutzfeldt-Jakob disease. Ann Clin Transl Neurol 2021;8:1183-99. [PMID: 33949799 DOI: 10.1002/acn3.51290] [Reference Citation Analysis]
43 Paterson RW, Torres-Chae CC, Kuo AL, Ando T, Nguyen EA, Wong K, DeArmond SJ, Haman A, Garcia P, Johnson DY, Miller BL, Geschwind MD. Differential diagnosis of Jakob-Creutzfeldt disease. Arch Neurol 2012;69:1578-82. [PMID: 23229042 DOI: 10.1001/2013.jamaneurol.79] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
44 Coulthart MB, Jansen GH, Cashman NR. Interpretation of cerebrospinal fluid protein tests in the diagnosis of sporadic Creutzfeldt-Jakob disease: an evidence-based approach. CMAJ 2014;186:E333-9. [PMID: 24446456 DOI: 10.1503/cmaj.130720] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
45 Figgie MP Jr, Appleby BS. Clinical Use of Improved Diagnostic Testing for Detection of Prion Disease. Viruses 2021;13:789. [PMID: 33925126 DOI: 10.3390/v13050789] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Riancho J, Delgado-alvarado M, Fernández-torre JL, Sánchez-juan P, Polo JM. Subacute progressive aphasia: a rare presentation of Creutzfeldt–Jakob disease. J Neurol 2016;263:600-2. [DOI: 10.1007/s00415-016-8054-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
47 Yang TI, Jung DS, Ahn BY, Jeong BH, Cho HJ, Kim YS, Na DL, Geschwind MD, Kim EJ. Familial Creutzfeldt-Jakob disease with V180I mutation. J Korean Med Sci 2010;25:1097-100. [PMID: 20592908 DOI: 10.3346/jkms.2010.25.7.1097] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
48 Pellegrini F, Stafa A, Bonsanto D, Fraser CL. The dark side of the (half) moon. Surv Ophthalmol 2020;65:381-5. [PMID: 30772362 DOI: 10.1016/j.survophthal.2019.02.001] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Johnson DY, Dunkelberger DL, Henry M, Haman A, Greicius MD, Wong K, DeArmond SJ, Miller BL, Gorno-Tempini ML, Geschwind MD. Sporadic Jakob-Creutzfeldt disease presenting as primary progressive aphasia. JAMA Neurol 2013;70:254-7. [PMID: 23400721 DOI: 10.1001/2013.jamaneurol.139] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
50 Chuang DT, O'Dowd MA, Frieder A, Haut SR, Robbins MS. Delayed diagnosis of sporadic Creutzfeldt-Jakob disease in a patient with schizophrenia. Psychosomatics 2012;53:392-6. [PMID: 22458988 DOI: 10.1016/j.psym.2011.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
51 Geschwind MD. Rapidly progressive dementia: prion diseases and other rapid dementias. Continuum (Minneap Minn) 2010;16:31-56. [PMID: 22810280 DOI: 10.1212/01.CON.0000368211.79211.4c] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
52 Park Y, Lee CN. A Case of Creutzfeldt-Jakob Disease Presented as Rapid Progressive Parkinsonism. Dement Neurocogn Disord 2019;18:152-6. [PMID: 31942175 DOI: 10.12779/dnd.2019.18.4.152] [Reference Citation Analysis]
53 Song J, Yang D, Seo H, Ha S, Park K, Kwon O, Youn YC. Conduction aphasia as an initial symptom in a patient with Creutzfeldt–Jakob disease. Journal of Clinical Neuroscience 2010;17:1341-3. [DOI: 10.1016/j.jocn.2010.02.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
54 Krasnianski A, Kaune J, Jung K, Kretzschmar HA, Zerr I. First symptom and initial diagnosis in sporadic CJD patients in Germany. J Neurol 2014;261:1811-7. [DOI: 10.1007/s00415-014-7410-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
55 Schaffert LN, Carter WG. Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review. Brain Sci 2020;10:E232. [PMID: 32290481 DOI: 10.3390/brainsci10040232] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
56 Sai T, Imai K, Tsuto K, Yamamoto A, Ioku T, Matsuo K. A case of genetic Creutzfeldt–Jakob disease that required differential diagnosis of acute encephalopathy associated with Sjogren’s syndrome. Rinsho Shinkeigaku. [DOI: 10.5692/clinicalneurol.cn-001672] [Reference Citation Analysis]
57 Rus T, Lorber B, Trošt M, Dobrecovič S, Čakš Jager N, Popović M, Kramberger MG. High Incidence of Sporadic Creutzfeldt-Jakob Disease in Slovenia in 2015: A Case Series. Dement Geriatr Cogn Dis Extra 2018;8:42-50. [PMID: 29515622 DOI: 10.1159/000486712] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Negm M, Hashish E. Probable Creutzfeldt-Jakob disease—a case report at Suez Canal University Hospital, Egypt. Egypt J Neurol Psychiatry Neurosurg 2019;55. [DOI: 10.1186/s41983-019-0085-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
59 Cumbler E, Furfari K, Guerrasio J. Creutzfeldt-Jacob disease presenting as severe depression: a case report. Cases J 2009;2:122. [PMID: 19193205 DOI: 10.1186/1757-1626-2-122] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
60 Geschwind MD. Prion Diseases. Continuum (Minneap Minn) 2015;21:1612-38. [PMID: 26633779 DOI: 10.1212/CON.0000000000000251] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
61 Goodwill VS, Dryden I, Choi J, De Lillo C, Soldau K, Llibre-Guerra J, Sanchez H, Sigurdson CJ, Lin JH. Minimal change prion retinopathy: Morphometric comparison of retinal and brain prion deposits in Creutzfeldt-Jakob disease. Exp Eye Res 2022;222:109172. [PMID: 35803332 DOI: 10.1016/j.exer.2022.109172] [Reference Citation Analysis]
62 Ahmed RM, Halmagyi GM, Rodriguez ML. Rapidly progressive dementia and ataxia in an elderly man. Pract Neurol 2013;13:165-73. [PMID: 23487816 DOI: 10.1136/practneurol-2012-000443] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
63 Tang S, Dou X, Zhang Y. 18F-FP-CIT PET/CT in a case of probable sporadic Creutzfeldt-Jakob disease with parkinsonism as initial symptom. Prion 2022;16:91-4. [PMID: 35801711 DOI: 10.1080/19336896.2022.2093078] [Reference Citation Analysis]
64 Minikel EV, Zerr I, Collins SJ, Ponto C, Boyd A, Klug G, Karch A, Kenny J, Collinge J, Takada LT, Forner S, Fong JC, Mead S, Geschwind MD. Ascertainment bias causes false signal of anticipation in genetic prion disease. Am J Hum Genet 2014;95:371-82. [PMID: 25279981 DOI: 10.1016/j.ajhg.2014.09.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
65 Geschwind MD, Haman A, Miller BL. Rapidly progressive dementia. Neurol Clin 2007;25:783-807, vii. [PMID: 17659190 DOI: 10.1016/j.ncl.2007.04.001] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 3.7] [Reference Citation Analysis]
66 Velásquez-Pérez L, Rembao-Bojorquez D, Guevara J, Guadarrama-Torres RM, Trejo-Contreras A. Creutzfeldt-Jakob disease in Mexico. Neuropathology 2007;27:419-28. [PMID: 18018474 DOI: 10.1111/j.1440-1789.2007.00807.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
67 Connor A, Wang H, Appleby BS, Rhoads DD. Clinical Laboratory Tests Used To Aid in Diagnosis of Human Prion Disease. J Clin Microbiol 2019;57:e00769-19. [PMID: 31366689 DOI: 10.1128/JCM.00769-19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
68 Day GS. Rapidly Progressive Dementia. Continuum (Minneap Minn) 2022;28:901-36. [PMID: 35678409 DOI: 10.1212/CON.0000000000001089] [Reference Citation Analysis]
69 Chen S, He S, Xu YY, Teng HY, Zhang JW. Clinical Presentation of Sporadic Creutzfeldt-Jakob Disease in Han-Chinese. Alzheimer Dis Assoc Disord 2020;34:188-90. [PMID: 31651418 DOI: 10.1097/WAD.0000000000000350] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Geschwind MD. Doxycycline for Creutzfeldt-Jakob disease: a failure, but a step in the right direction. The Lancet Neurology 2014;13:130-2. [DOI: 10.1016/s1474-4422(14)70001-8] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]